GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD

Andere talen Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Aandelen

300534

CNE100002CP5

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,23 ^CNY	+0,98%		+3,26%	-16,62%

26/04	Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
24/04	Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD doet slotdividend in contanten voor 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Proposes Final Cash Dividend for 2023	24/04
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023	23/04
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD cancelled the transaction announced on July 17, 2023	21/03
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	17-10-23
Longshenrongfa Pharmaceutical Renews Food Production License	14-09-23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	25-08-23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD announced that it expects to receive CNY 485.796067 million in funding from Gansu Pharmaceutical Investment Group Co., Ltd., Gansu Great Wall Xinglong Silk Road Fund Management Co., Ltd. and other investors.	17-07-23
An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.	05-06-23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	24-04-23
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022	14-04-23
Chinese Shares Rebound; Longshenrongfa Pharma Rises 3.9% on Renewal of Drug Production License	15-03-23
Gansu Longshenrongfa Pharma Renews Drug Production License	15-03-23
Drug Regulator Approves Changes to Longshenrongfa Pharma's Drug Production License	16-02-23
Longshenrongfa Pharma Gets Nod for Proposed Changes in License	10-02-23
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd completed the acquisition of 70% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd.	07-02-23
Longshenrongfa Pharma Gets Provincial Regulator's Nod for Cough Capsules	06-01-23
Gansu Longshenrongfa Leases Properties to Affiliates	14-11-22
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	26-10-22
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022	25-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Aandelen

300534

CNE100002CP5

Andere talen

Filters